What is the latest price of Glasdegib/Glasdegib in 2025?

Glasdegib is a first-choice treatment for acute myeloid leukemia (AML), especially in adults whose cancer starts in their white blood cells or who have other conditions that preclude traditional chemotherapy drugs. It belongs to a class of drugs called hedgehog signaling pathway inhibitors, which help slow the spread of cancer cells by effectively blocking the activity of a protein that promotes cancer cell reproduction.

In terms of medication method, Glasgib is provided in the form of oral tablets, and patients are usually recommended to take it once a day for at least 6 months, or as recommended by their doctor. Patients can choose to take it with or without food, but be sure to take it at the same time to help create a routine. Patients should strictly follow the instructions on the prescription label and consult their doctor or pharmacist if they are unsure. It is important that the tablets are swallowed whole and never cut, chewed or crushed to ensure they are effective.

If vomiting occurs after taking Glasgib, patients should not resume taking an alternative dose but should continue on their regular medication schedule. During treatment, doctors may need to adjust the dosage or temporarily interrupt treatment based on the patient's response to the drug and side effects. Therefore, patients should promptly feedback their feelings to the doctor during treatment with Glasgib in order to obtain the best individualized treatment plan.

Glasgib’s original drug has not yet been launched in China, so its price and medical insurance information are not yet clear. Currently, the European version of Glasgib is sold overseas. The common specification is 100mg*30 tablets. The price per box may be RMB 80,000 to 90,000. This price may fluctuate due to the exchange rate. In addition, there are no generics of Glasgib available for sale at home and abroad. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://medlineplus.gov/druginfo/meds/a619004.html